In the US, Gammagard (immune globulin intravenous and subcutaneous systemic) is a member of the drug class immune globulins and is used to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Idiopathic Thrombocytopenic Purpura, Multifocal Motor Neuropathy and Primary Immunodeficiency Syndrome.
Ingredient matches for Gammagard
Human Normal Immune Globulin is reported as an ingredient of Gammagard in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.